Literature DB >> 31602355

Frailty and Outcomes After Liver Transplantation.

Elliot B Tapper1,2.   

Abstract

PURPOSE OF REVIEW: Frailty is an emerging concept in liver transplantation. We reviewed the literature for the tests of frailty which have been validated to predict outcomes in patients with cirrhosis evaluated for liver transplantation. RECENT
FINDINGS: Several tools have been developed to further stratify risk of adverse events independent of liver disease severity. These include tests of disability such as activities of daily living and the Karnofsky Performance Score as well as tests of physical frailty such as the Liver Frailty Index (hand-grip, chair stands, and balance).
SUMMARY: Increasingly, the frailty assessment is seen as a critical component of the liver transplant evaluation. Further research is needed to clarify the optimal timing of testing and the implications of longitudinal change.

Entities:  

Keywords:  Cirrhosis; Hepatic Encephalopathy; Liver Disease; Portal Hypertension

Year:  2019        PMID: 31602355      PMCID: PMC6786794          DOI: 10.1007/s40472-019-0222-4

Source DB:  PubMed          Journal:  Curr Transplant Rep


  25 in total

1.  Functional status predicts postoperative mortality after liver transplantation.

Authors:  Natasha H Dolgin; Paulo N A Martins; Babak Movahedi; Kate L Lapane; Fred A Anderson; Adel Bozorgzadeh
Journal:  Clin Transplant       Date:  2016-10-20       Impact factor: 2.863

2.  Karnofsky performance status before and after liver transplantation predicts graft and patient survival.

Authors:  Paul J Thuluvath; Avesh J Thuluvath; Yulia Savva
Journal:  J Hepatol       Date:  2018-06-06       Impact factor: 25.083

3.  A Rapid Bedside Screen to Predict Unplanned Hospitalization and Death in Outpatients With Cirrhosis: A Prospective Evaluation of the Clinical Frailty Scale.

Authors:  Puneeta Tandon; Navdeep Tangri; Lesley Thomas; Laura Zenith; Tahira Shaikh; Michelle Carbonneau; Mang Ma; Robert J Bailey; Saumya Jayakumar; Kelly W Burak; Juan G Abraldes; Amanda Brisebois; Thomas Ferguson; Sumit R Majumdar
Journal:  Am J Gastroenterol       Date:  2016-08-02       Impact factor: 10.864

4.  Disability in patients with end-stage liver disease: Results from the functional assessment in liver transplantation study.

Authors:  Mariya L Samoylova; Kenneth E Covinsky; Marta Haftek; Selena Kuo; John P Roberts; Jennifer C Lai
Journal:  Liver Transpl       Date:  2017-03       Impact factor: 5.799

Review 5.  Systematic review: pre- and post-operative prognostic value of cardiopulmonary exercise testing in liver transplant candidates.

Authors:  M Ney; M J Haykowsky; B Vandermeer; A Shah; M Ow; P Tandon
Journal:  Aliment Pharmacol Ther       Date:  2016-08-19       Impact factor: 8.171

6.  Six-minute walk distance predicts mortality in liver transplant candidates.

Authors:  Elizabeth J Carey; D Eric Steidley; Bashar A Aqel; Thomas J Byrne; Kristin L Mekeel; Jorge Rakela; Hugo E Vargas; David D Douglas
Journal:  Liver Transpl       Date:  2010-12       Impact factor: 5.799

7.  Frailty predicts waitlist mortality in liver transplant candidates.

Authors:  J C Lai; S Feng; N A Terrault; B Lizaola; H Hayssen; K Covinsky
Journal:  Am J Transplant       Date:  2014-06-16       Impact factor: 8.086

8.  Depression and Frailty in Patients With End-Stage Liver Disease Referred for Transplant Evaluation.

Authors:  D C Cron; J F Friedman; G S Winder; A E Thelen; J E Derck; J W Fakhoury; A D Gerebics; M J Englesbe; C J Sonnenday
Journal:  Am J Transplant       Date:  2016-02-24       Impact factor: 8.086

9.  Poor Performance Status Is Associated With Increased Mortality in Patients With Cirrhosis.

Authors:  Eric S Orman; Marwan Ghabril; Naga Chalasani
Journal:  Clin Gastroenterol Hepatol       Date:  2016-04-01       Impact factor: 11.382

10.  Aerobic capacity during cardiopulmonary exercise testing and survival with and without liver transplantation for patients with chronic liver disease.

Authors:  William Bernal; Rosa Martin-Mateos; Miklós Lipcsey; Caroline Tallis; Kyne Woodsford; Mark J McPhail; Christopher Willars; Georg Auzinger; Elizabeth Sizer; Michael Heneghan; Simon Cottam; Nigel Heaton; Julia Wendon
Journal:  Liver Transpl       Date:  2013-11-29       Impact factor: 5.799

View more
  5 in total

1.  Sarcopenia and Frailty in Chronic Liver Damage: Common and Different Points.

Authors:  Hiroki Nishikawa; Kazunori Yoh; Hirayuki Enomoto; Yoshinori Iwata; Yoshiyuki Sakai; Kyohei Kishino; Yoshihiro Shimono; Naoto Ikeda; Tomoyuki Takashima; Nobuhiro Aizawa; Ryo Takata; Kunihiro Hasegawa; Takashi Koriyama; Yukihisa Yuri; Takashi Nishimura; Shuhei Nishiguchi; Hiroko Iijima
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

2.  A Claims-Based Frailty Risk Score Is Associated With Hospitalization for Acute-on-Chronic Liver Failure: But Is It Frailty?

Authors:  Jeremy Louissaint; Elliot B Tapper
Journal:  Liver Transpl       Date:  2020-11-08       Impact factor: 5.799

3.  Applying Administrative Data-Based Coding Algorithms for Frailty in Patients With Cirrhosis.

Authors:  Jeremy Louissaint; Susan L Murphy; Christopher J Sonnenday; Anna S Lok; Elliot B Tapper
Journal:  Liver Transpl       Date:  2021-07-31       Impact factor: 5.799

4.  Karnofsky performance status predicts outcomes in candidates for simultaneous liver-kidney transplant.

Authors:  Hani Shamseddeen; Francis Pike; Marwan Ghabril; Kavish R Patidar; Archita P Desai; Lauren Nephew; Melissa Anderson; Chandrashekhar Kubal; Naga Chalasani; Eric S Orman
Journal:  Clin Transplant       Date:  2020-12-29       Impact factor: 3.456

5.  Serum Zinc Level Is Associated with Frailty in Chronic Liver Diseases.

Authors:  Hiroki Nishikawa; Kazunori Yoh; Hirayuki Enomoto; Yoshinori Iwata; Yoshiyuki Sakai; Kyohei Kishino; Yoshihiro Shimono; Naoto Ikeda; Tomoyuki Takashima; Nobuhiro Aizawa; Ryo Takata; Kunihiro Hasegawa; Takashi Koriyama; Yukihisa Yuri; Takashi Nishimura; Shuhei Nishiguchi; Hiroko Iijima
Journal:  J Clin Med       Date:  2020-05-22       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.